Literature DB >> 12523320

Overview of clinical PET.

M N Maisey1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12523320     DOI： 10.1259/bjr.75.suppl_9.750001

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  9 in total

1.  A plea for the elective inclusion of the brain in routine whole-body FDG PET.

Authors:  Tarik Belhocine; Stefan Markus Weiner; Ingo Brink; Peter Paul De Deyn; Jan Roland; Thierry Van der Borght; Patrick Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

2.  Endoscopic evaluation of gastrointestinal lesions noted incidentally on PET scanning.

Authors:  Donald S David; Glen R Gibson; Frederic Grannis
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

3.  The timing of adoption of positron emission tomography: a real options approach.

Authors:  Paolo Pertile; Emanuele Torri; Luciano Flor; Stefano Tardivo
Journal:  Health Care Manag Sci       Date:  2009-09

4.  The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.

Authors:  LingLing Pan; JingYi Cheng; Min Zhou; ZhiFeng Yao; YingJian Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-20       Impact factor: 4.553

Review 5.  Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignancies.

Authors:  Long Sun; Hua Wu; Yong-Song Guan
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

Review 6.  The choice of the correct imaging modality in breast cancer management.

Authors:  Emilio Bombardieri; Luca Gianni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-04       Impact factor: 9.236

7.  FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.

Authors:  Letizia Deantonio; Debora Beldì; Giuseppina Gambaro; Gianfranco Loi; Marco Brambilla; Eugenio Inglese; Marco Krengli
Journal:  Radiat Oncol       Date:  2008-09-18       Impact factor: 3.481

8.  The role of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with mycosis fungoides.

Authors:  Eiman Alanteri; Sharjeel Usmani; Fahad Marafi; Abulredha Esmail; Abdullah Ali; Rehab S Elhagracy; Salem Alshemmari
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep

Review 9.  Mycosis fungoides staged by 18F-flurodeoxyglucose positron emission tomography/computed tomography: Case report and review of literature.

Authors:  Lu Xu; Hua Pang; Jin Zhu; Xi Chen; Lili Guan; Jie Wang; Jing Chen; Ying Liu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.